Real World Treatment Experience of Patients With Breast, Lung, or GI Cancer or Multiple Myeloma Using Remote Symptom Monitoring
Study Details
Study Description
Brief Summary
The Carevive registry collects patient characteristics, patient symptoms, and treatment experience data from patients receiving cancer treatment for breast, lung, GI or multiple myeloma. For this study, a core set of variables is collected on each patient in the Carevive platform. Patients will complete a baseline survey in person using a secured device or remotely using their own electronic device in a location of their choice. Weekly electronic Patient Reported Outcome surveys are collected from the patients using the Carevive platform for a minimum of 12 weeks. Patients may continue weekly surveys as long as they are receiving treatment.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Outcome Measures
Primary Outcome Measures
- Create data set [12 weeks]
Project outcome measures for this project are the prevalence, frequency, and severity of symptoms in each disease group, longitudinal change in symptom experience, and time on treatment from enrollment to next treatment.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
All participants must be 18 years of age or older.
-
Subjects may be any stage and anywhere in the treatment continuum.
-
Subject participants must have a diagnosis of breast, lung, GI or ovarian cancer or multiple myeloma.
-
Subjects must be able to complete on-line surveys using a cell phone, tablet, or computer.
-
All participants must be able to understand English.
Exclusion Criteria:
-
Any patient who cannot understand written or spoken English.
-
Any patient without the ability to complete on-line surveys using a cell phone, tablet, or computer.
-
Any patient on a treatment clinical trial.
-
Any prisoner and/or other vulnerable persons as defined by NIH (45 CFR 46, Subpart B, C and D).
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Cleveland Clinic | Cleveland | Ohio | United States | 44131 |
Sponsors and Collaborators
- Carevive Systems, Inc.
Investigators
- Study Director: Aaron Galaznik, MD, Carevive Systems, Inc.
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- OPT-IN Research Protocol